These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 22178693)

  • 1. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Hematol Oncol Stem Cell Ther; 2012; 5(1):1-30. PubMed ID: 22446607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Bone Marrow Transplant; 2012 Mar; 47(3):337-41. PubMed ID: 22395764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation].
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Rinsho Ketsueki; 2014 Jun; 55(6):607-32. PubMed ID: 24975331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Lint MT; Wingard JR; Tichelli A
    Rev Bras Hematol Hemoter; 2012; 34(2):109-33. PubMed ID: 23049402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.
    Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GMT; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
    Bone Marrow Transplant; 2024 Jun; 59(6):717-741. PubMed ID: 38413823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
    Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GM; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R
    Transplant Cell Ther; 2024 Apr; 30(4):349-385. PubMed ID: 38413247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surviving the cure: long term followup of hematopoietic cell transplant recipients.
    Majhail NS; Rizzo JD
    Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.
    Saunders IM; Tan M; Koura D; Young R
    Pharmacotherapy; 2020 Aug; 40(8):808-841. PubMed ID: 32652612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
    Bevans M; El-Jawahri A; Tierney DK; Wiener L; Wood WA; Hoodin F; Kent EE; Jacobsen PB; Lee SJ; Hsieh MM; Denzen EM; Syrjala KL
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):538-551. PubMed ID: 27660168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term complications after hematopoietic cell transplantation.
    Majhail NS
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):220-227. PubMed ID: 28641097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
    Saad A; de Lima M; Anand S; Bhatt VR; Bookout R; Chen G; Couriel D; Di Stasi A; El-Jawahri A; Giralt S; Gutman J; Ho V; Horwitz M; Hsu J; Juckett M; Kharfan-Dabaja MA; Loren A; Meade J; Mielcarek M; Moreira J; Nakamura R; Nieto Y; Roddy J; Satyanarayana G; Schroeder M; Tan CR; Tzachanis D; Burn J; Pluchino L
    J Natl Compr Canc Netw; 2020 May; 18(5):599-634. PubMed ID: 32519831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
    Morton LM; Saber W; Baker KS; Barrett AJ; Bhatia S; Engels EA; Gadalla SM; Kleiner DE; Pavletic S; Burns LJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):367-378. PubMed ID: 27634019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
    Pulsipher MA; Skinner R; McDonald GB; Hingorani S; Armenian SH; Cooke KR; Gracia C; Petryk A; Bhatia S; Bunin N; Nieder ML; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Baker KS
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):334-47. PubMed ID: 22248713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
    Tomblyn MB; Arora M; Baker KS; Blazar BR; Brunstein CG; Burns LJ; DeFor TE; Dusenbery KE; Kaufman DS; Kersey JH; MacMillan ML; McGlave PB; Miller JS; Orchard PJ; Slungaard A; Tomblyn MR; Vercellotti GM; Verneris MR; Wagner JE; Weisdorf DJ
    J Clin Oncol; 2009 Aug; 27(22):3634-41. PubMed ID: 19581540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
    Hashmi SK; Lee SJ; Savani BN; Burns L; Wingard JR; Perales MA; Palmer J; Chow E; Meyer E; Marks D; Mohty M; Inamoto Y; Rodriguez C; Nagler A; Sauter C; Komanduri KV; Pidala J; Hamadani M; Johnston L; Shah N; Shaughnessy P; Hamilton BK; Majhail N; Kharfan-Dabaja MA; Schriber J; DeFilipp Z; Tarlock KG; Fanning S; Curtin P; Rizzo JD; Carpenter PA
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1119-1124. PubMed ID: 29608957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.